A Case of Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Metaplastic Breast Cancer

JCO Precis Oncol. 2023 May:7:e2200506. doi: 10.1200/PO.22.00506.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Neoadjuvant Therapy

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized